After losing his voice to cancer, this founder is building “glasses for voice”

The ability to communicate with emotional nuance is now available as a purchasable device, not just a medical necessity.

Konrad Zieliński, who lost his voice to cancer, has founded Uhura Bionics to develop non-invasive wearable devices that restore vocal expression for laryngectomees. Traditional solutions, like handheld speaking devices or surgically implanted prostheses, are often limited in their emotional range and require significant maintenance. Zieliński's company offers two models, including a high-end version named Whitney, designed to allow users to speak with emotion, laugh, shout, and even sing. Uhura Bionics is targeting a $2 billion market for laryngectomee devices, with potential to expand to other speech disorders. The startup is currently selling its devices as wellness products, priced at $500 for a basic model and $1,500 for Whitney, with plans to pursue Class I medical device classification in Europe and the U.S. for potential insurance reimbursement. Uhura Bionics is one of several companies, including Atos Medical and Laronix, innovating in this space.

Uhura Bionics' 'glasses for voice' represent a significant leap beyond traditional assistive communication devices, focusing on restoring emotional expressiveness rather than just basic vocalization. By aiming for Class I medical device status, the company is positioning itself to make these advanced vocal prosthetics accessible through insurance, potentially democratizing a technology previously limited to out-of-pocket purchases. This move signals a broader trend toward integrating sophisticated AI and bio-mimicry into everyday assistive technologies, blurring the lines between medical devices and consumer electronics.

The competitive landscape, including established players like Atos Medical and other startups, suggests a growing market interest in advanced speech restoration. Uhura's strategy of demonstrating capabilities through public performances, like singing onstage, highlights a focus on user experience and emotional output, which could set a new standard for what users expect from voice prosthetics. As the technology matures and expands beyond laryngectomees, it could impact individuals with a wide range of speech impediments, broadening the market and driving further innovation in personalized and expressive AI-driven communication aids.